Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Authors:
- 20 August 2020
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 95 (10) , 1209-1213
Abstract
Disease Overview: Approximately one‐fourth of primary cutaneous lymphomas are B‐cell derived and are generally classified into three distinct subgroups: primary cutaneous follicle center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), and primary cutaneous diffuse large B‐cell lymphoma, leg type (PCDLBCL, LT).Diagnosis: Diagnosis and disease classification is based on histopathologic review and immunohistochemical staining of an appropriate skin biopsy. Pathologic review and an appropriate staging evaluation are necessary to distinguish primary cutaneous B‐cell lymphomas from systemic B‐cell lymphomas with secondary skin involvement.Risk‐Stratification: Disease histopathology remains the most important prognostic determinant in primary cutaneous B‐cell lymphomas. Both PCFCL and PCMZL are indolent lymphomas that infrequently disseminate to extracutaneous sites and are associated with 5‐year survival rates that exceed 95%. In contrast, PCDLBCL, LT is an aggressive lymphoma with an inferior prognosis.Risk‐Adapted Therapy: Both PCFCL and PCMZL patients with solitary or relatively few skin lesions may be effectively managed with local radiation therapy. While single‐agent rituximab may be employed for patients with more widespread skin involvement, multi‐agent chemotherapy is rarely appropriate. In contrast, management of patients with PCDLBCL, LT is comparable to the management of patients with systemic DLBCL.Keywords
This publication has 48 references indexed in Scilit:
- Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 SubsetsAmerican Journal of Surgical Pathology, 2010
- Intralesional corticosteroid therapy for primary cutaneous B-cell lymphomaBritish Journal of Dermatology, 2010
- Long-Term Evolution of an Untreated Primary Cutaneous Follicle Center Lymphoma of the ScalpThe American Journal of Dermatopathology, 2010
- Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 casesBlood, 2009
- Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeJournal of Investigative Dermatology, 2009
- The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environmentBlood, 2008
- Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous LymphomasJournal of Clinical Oncology, 2006
- Molecular Cytogenetic Analysis of Chromosomal Breakpoints in the IGH, MYC, BCL6, and MALT1 Gene Loci in Primary Cutaneous B-cell LymphomasJournal of Investigative Dermatology, 2004
- Immunoreactivity for bcl‐2 protein in cutaneous lymphomas and lymphoid hyperplasiasJournal of Cutaneous Pathology, 1995
- bcl-2 Protein Expression and Correlation with the Interchromosomal 14;18 Translocation in Cutaneous Lymphomas and PseudolymphomasJournal of Investigative Dermatology, 1994